October 24-26, the World Pharmaceutical Raw Materials Expo (CPHI Worldwide), the United States Natural, health and innovative raw materials (West) exhibition (SupplySide West) were held in Spain and the United States, as an important global supplier of pharmaceutical and health food raw materials. Erkang Pharmaceutical with ace products tapioca starch (capsule), sodium citrate, caffeine and other advantages of raw materials products wonderful appearance in two industry events, highly recognized by the majority of enterprises.
It is understood that Supplyside West has developed into the world’s important international exhibition of natural extracts, health care raw materials and food additives, attracting more than 1600 related companies from all over the world to participate in the exhibition, CPHI Worldwide is the world’s largest pharmaceutical industry professional exhibition, but also the global pharmaceutical industry’s weather indicator exhibition. At two international exhibitions, Ercon Pharmaceuticals showcased its high-quality core products and global service capabilities to customers around the world.
Starch plant capsule has become the industry development trend
According to HTF Market Intelligence company data show that from 2023 to 2028, the global plant softgel market is expected to grow by 6.9%, the market size may reach 618.7 million US dollars in 2028, “plant capsule” has become a new trend in the consumption of softgel dosage forms, and the market prospect is broad.\
Erkang Pharmaceutical has brought its popular products Starchgel® (starch for plant softgel capsules) and N-VGEL® (starch for chewable softgel capsules), which have received great attention because they meet customers’ demands for “non-GMO” and “natural safety”. Relying on many years of scientific research and innovation advantages in the field of plant capsules, Erkang Pharmaceutical has maintained a strong market position for many years, serving the global 1000+ nutrition brands.
Superior raw materials and intermediate products have become a new favorite
In addition to starch capsule products, Erkang Pharmaceutical also brought Caffeine (Caffeine), Sodium Citrate (Sodium Citrate), Sulfadiazine (Sulfadiazine), Rutin and other advantages of products, professional system of raw materials and intermediate solutions to attract many customers to visit the booth exchange.
As a leading pharmaceutical excipients enterprise in China, Erkang laid out the industrial park in Cambodia in 2013, with a total investment of more than 400 million US dollars in the past ten years, and the park projects cover a number of key core products in the pharmaceutical and health food industry such as apis, pharmaceutical intermediates and pharmaceutical excipients. At present, the annual production capacity of cassava starch reaches 180,000 tons, the annual production capacity of sodium citrate reaches 50,000 tons, and the annual production capacity of caffeine reaches 10,000 tons. Erkang Cambodia Industrial Park can also supply sulphadiazine, p-aminophenol, m-dinitrobenzene, theophylline sodium and other key raw materials and pharmaceutical intermediates. With multiple advantages such as origin resources, policies and production scale, Erkang Pharmaceutical products have gone global.
At the two exhibitions, many industry insiders said that “plant-based” is an important trend in the development of the health industry, and the plant gum softgel made by Erkang cassava starch is a new choice for the upgrade of softgel categories. The API and intermediates series products provided by Erkang Pharmaceutical not only have a wide range of industry applications, but also have a strong competitive advantage in terms of capacity supply and production quality.
All along, Erkang Pharmaceutical has paid close attention to new market trends, actively grasped the new direction of industry development, and constantly innovated in the field of research and development and production. In August this year, Erkang Pharmaceutical became the first enterprise in China to obtain the international certification of NSF dietary Supplement GMP raw material and finished product dual standards (NSF173 GMPDI, NSF/ANSI 455-2), which is a heavy honor and achievement to encourage Erkang Pharmaceutical to continue to move forward. In the future, Erkang will continue to rapidly promote the company’s international layout, enhance the core competitiveness of products, and bring more natural and safe solutions to customers in the global pharmaceutical, health care products, food and other industries with world-class production technology and more stringent manufacturing standards, and join hands with global consumers to a better and healthy future!
